To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Fetal and Neonatal Heart Monitor Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Global demand for fetal and neonatal heart monitors stands at US$ 8.9 billion in 2023 and is predicted to increase at a healthy 5.5% CAGR over the next ten years. By 2033-end, the global fetal and neonatal heart monitor market is thus expected to secure US$ 15.2 billion in revenue.
Fetal and neonatal heart monitors are used to check the heartbeat and heart rate of unborn babies in their mother’s wombs. These monitors are essentially used in gynecology procedures through labor and delivery to monitor the health of the fetus. Increasing focus on fetal health monitoring, rapid advancements in medical diagnostic equipment technologies, and growing awareness regarding preterm births and stillbirths are key factors that are estimated to boost demand for fetal and neonatal heart monitors in the future.
The launch of new initiatives to reduce the mortality rate among newborn babies by governments and non-profit organizations is also projected to promote sales of fetal and neonatal heart monitors over the next ten years. The rising number of babies requiring care through neonatal intensive care units (NICUs) is also projected to uplift shipments of fetal and neonatal heart monitors across the forecast period.
Surging popularity of non-invasive and minimally invasive devices is projected to offer new opportunities for fetal and neonatal heart monitor producers over the coming years. However, stringent regulatory mandates and safety regulations are expected to prove to be major challenges that market players will have to overcome in the future.
On the contrary, declining birth rates and evolving preferences of women to have children late or not have children at all are expected to hurt fetal and neonatal heart monitor shipments in the long run. The absence of developed healthcare infrastructure and lack of proper availability of neonatal care are also expected to foil market growth throughout the forecast period.
An exhaustive analysis of growth-altering aspects such as supply chain management, local supply, and other trends has been mentioned in this fetal and neonatal heart monitor market research study by Fact.MR, a market research and competitive intelligence provider.
Report Attributes |
Details |
Market Size (2023) |
US$ 8.9 Billion |
Projected Market Value (2033F) |
US$ 15.2 Billion |
Global Market Growth Rate (2023 to 2033) |
5.5% CAGR |
Leading Regional Market (2023) |
Asia Pacific |
Key Companies Profiled |
|
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“New Companies Focusing on Innovation and Capital Raising to Advance Neonatal Care”
New fetal and neonatal heart monitor suppliers are focusing on integrating advanced technologies such as artificial intelligence (AI), machine learning, etc. to improve the capability of their neonatal devices.
New fetal monitor manufacturers are also raising new finance to fund their research and development activity and advance their business scope around the world.
More insights about new developments by fetal and neonatal heart monitor start-ups and how they are affecting product standards and pricing trends have been extensively discussed in this latest Fact.MR research study.
“Increasing Awareness Regarding Fetal Health to Boost Market Growth”
The developed healthcare infrastructure of the United States creates an opportune scenario for fetal and neonatal heart monitor providers. Rising awareness regarding neonatal health monitoring and growing spending on fetal care among pregnant women in the country are also projected to uplift fetal and neonatal heart monitor sales in the future. High investments in medical research and development activities in the United States are also anticipated to favor market growth in the long term.
Declining birth rates and a rising number of preterm births are factors that could promote the adoption of neonatal and fetal care devices in the country going forward.
Favorable reimbursement policies and the presence of good medical insurance coverage for neonatal care in the United States are projected to promote demand for fetal and neonatal heart monitors over the coming years through 2033.
“Declining Birth Rates to Affect Shipments of Fetal Heart Monitors”
Japan and South Korea have been witnessing a drop in birth rates over the past few years and the problem has been worsening in recent years as these countries hit record lows. The rapid aging of the population of these countries is another prospect that contributes to the plummeting birth rates among other factors.
Rapid urbanization and modernization in Japan and South Korea have also majorly contributed to declining birth rates in the countries and hence are projected to hurt demand for fetal and neonatal heart monitors in the future. However, governments in both of the aforementioned countries are focusing on solving this population issue by launching new initiatives to help uplift birthrates and bring about some fundamental changes to society to alleviate the stress on the economy that has been caused by the rising geriatric population.
“Increasing Prevalence of Diabetes & Obesity to Bolster Demand for Neonatal Heart Monitors”
The number of premature/preterm births has been increasing in European countries in recent years and is projected to rise further over the coming years. This can be ascribed to the rising prevalence of obesity and diabetes among women, which in turn is boosting demand for fetal and neonatal care in countries such as Germany, Italy, the United Kingdom, etc.
High incidence of obesity, diabetes, and other health issues in women result in complications for unborn babies and also put their life at risk, which necessitates the use of neonatal monitoring and diagnostic equipment to keep them safe. Rising awareness regarding fetal health, a growing number of stillbirths and preterm births, and increasing healthcare expenditure are other factors that are predicted to augment sales of fetal and neonatal heart monitors in European countries over the next ten years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Hospitals Projected to Account for Significant Market Share”
Based on end user, the fetal and neonatal heart monitor market is segmented into hospitals, neonatal clinics, ambulatory surgical centers, and diagnostic centers.
Hospitals account for the majority of the fetal and neonatal heart monitor demand at present and are anticipated to maintain a similar stance across the forecast period as well. The rising rate of hospitalization and the installation of new neonatal care units in hospitals are key factors that are projected to bolster sales of fetal heart monitors and other neonatal care devices such as neonatal ventilators, neonatal dialysis equipment, etc. over the next ten years.
Rising awareness regarding pregnancy and fetal care in developing economies is also predicted to contribute to high shipments of fetal and neonatal heart monitors in hospitals through 2033.
Prime fetal and neonatal heart monitor suppliers are focusing on launching new and advanced products to expand their business potential and gain a competitive edge in the global landscape.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
The global fetal and neonatal heart monitor market is valued at US$ 8.9 billion in 2023.
Fetal and neonatal heart monitor sales are forecasted to reach US$ 15.2 billion by 2033-end.
Over the next ten years, worldwide sales of fetal and neonatal heart monitors are projected to rise at 5.5% CAGR.
Product type, modality, end user, and region are the key segments covered in this Fact.MR research survey.
Analogic Corporation, Siemens Healthlineers, Masimo Corporation, and Medtronic Plc. are key manufacturers of fetal and neonatal heart monitors.